Haya Therapeutics raised $5M with Humboldt Fund and Apollo Health Ventures Biotech Health services Pharma Investments 08 February 2022 Share:
Round value (USD): N/A Round investors: Bernina BioInvest Broadview Ventures Schroder Adveq Humboldt Apollo Health Ventures 4see ventures Company: Haya Therapeutics Industry: Biotech Health services Pharma
Rejuveron announced closing series B. Biotech Financial Services Health services Pharma Investments 21 March 2022
Scailyte announced a first close of a series A funding round. AI (big data) Biotech Health services Software Services Investments 09 January 2022
ten23 in an equity deal to be acquired by 3i. Biotech Health services Manufacturing Pharma Secondary 25 September 2021
Cellestia announced getting funded by SNGLR Capital Biotech Health services Manufacturing Investments 16 August 2021